Search results for: Alzheimer's
Filter search results
Inequalities in Dementia: Unveiling the Evidence and Forging a Path Towards Greater Understanding
26 June 2024
…to allow for inequalities in dementia to be effectively tackled. ‘Inequalities in Dementia: Unveiling the Evidence and Forging a Path Towards Greater Understanding’, was commissioned and funded by Alzheimer’s Society….
Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment
11 July 2023
…stability in the UK. This consulting report, ‘Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment’, was commissioned and funded by Alzheimer’s Research UK (ARUK)….
New publication: The current and future burden of late-onset dementia in the UK: estimates and interventions
10 May 2016
…– ageing rapidly, dementia has the potential to be a major future health concern. The new study, published in Alzheimers and Dementia, aimed to estimate the burden of late-onset dementia…
Evaluating Medical Innovation: The Societal View
8 April 2010
…factors are reviewed in the Briefing and case studies are provided for Alzheimer’s disease and multiple sclerosis. The authors acknowledge that including a broader range of factors in evaluations in…
Meeting the Challenges of Drug Development in 2022: Summary of OHE’s 50th Anniversary Conference
11 October 2012
…great unmet medical need today are very difficult to understand and to treat; for example, cancers, autoimmune diseases and neurological diseases such as Alzheimer’s. The speakers and panellists generally agreed…
OHE Study on Pharmaceutical R&D Costs Released
3 December 2012
…600% from the 1970s[3] to the 2000s[4]. Second, success rates for clinical development are falling as tougher therapeutic areas are tackled—e.g. neurology (Alzheimer’s), autoimmune diseases (arthritis), and oncology. Success rates…
The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region
14 April 2025
…are equity, informal carer health-related quality of life (HRQoL) spillovers, productivity, and wider health sector benefits. Two case studies in Alzheimer’s disease and Spinal Muscular Atrophy show that different ways…
NICE at 25: Technology Appraisals – Faster Access to Modern Treatment?
1 May 2024
…New treatments for Alzheimer’s disease look likely to be the next test for the technology appraisal processes and anticipated breakthroughs in areas such as digital health technologies and diagnostics will…
When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies
1 March 2022
…sclerosis Alzheimer’s disease Sickle cell disease Our earlier report on the measurement of QOL for HTA provides a summary of the potential alternatives to generic preference-based measures for measuring QOL. Click to…